Lv2
160 积分 2024-09-08 加入
Recombinant ADAMTS13 for the Treatment of Acute TTP Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Results from the Phase 3 Randomized, Controlled, Crossover Study and the Phase 3b Continuation Study
1个月前
已关闭
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura
1个月前
已完结
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
1个月前
已关闭
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura
1个月前
已完结
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
1个月前
已完结
Recombinant ADAMTS13 for the Treatment of Acute TTP Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Results from the Phase 3 Randomized, Controlled, Crossover Study and the Phase 3b Continuation Study
1个月前
已完结
Recombinant ADAMTS13 for the Treatment of Acute TTP Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Results from the Phase 3 Randomized, Controlled, Crossover Study and the Phase 3b Continuation Study
1个月前
已关闭
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
1个月前
已关闭
A successfully treated case of an acute presentation of congenital thrombotic thrombocytopenic purpura (Upshaw–Schulman syndrome) with decreased ADAMTS13 during late stage of pregnancy
1个月前
已完结
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura
1个月前
已完结
皖公网安备34019202002308
